AT356049B - Verfahren zur herstellung neuer derivate von 3- alkyl-1,9-dihydroxy- und -1- hydroxy-9-ketodibenzo(b,d)pyranen - Google Patents

Verfahren zur herstellung neuer derivate von 3- alkyl-1,9-dihydroxy- und -1- hydroxy-9-ketodibenzo(b,d)pyranen

Info

Publication number
AT356049B
AT356049B AT402377A AT402377A AT356049B AT 356049 B AT356049 B AT 356049B AT 402377 A AT402377 A AT 402377A AT 402377 A AT402377 A AT 402377A AT 356049 B AT356049 B AT 356049B
Authority
AT
Austria
Prior art keywords
ketodibenzo
pyrans
dihydroxy
hydroxy
alkyl
Prior art date
Application number
AT402377A
Other languages
English (en)
Other versions
ATA402377A (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA402377A publication Critical patent/ATA402377A/de
Application granted granted Critical
Publication of AT356049B publication Critical patent/AT356049B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/832—Bacillus
    • Y10S435/834—Bacillus cereus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/931—Mucor

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
AT402377A 1976-06-09 1977-06-07 Verfahren zur herstellung neuer derivate von 3- alkyl-1,9-dihydroxy- und -1- hydroxy-9-ketodibenzo(b,d)pyranen AT356049B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/694,512 US4064009A (en) 1976-06-09 1976-06-09 Novel 3-(oxygenated alkyl)-1,9-dihydroxy and 1-hydroxy-9-keto dibenzo[b,d]py

Publications (2)

Publication Number Publication Date
ATA402377A ATA402377A (de) 1979-09-15
AT356049B true AT356049B (de) 1980-04-10

Family

ID=24789127

Family Applications (1)

Application Number Title Priority Date Filing Date
AT402377A AT356049B (de) 1976-06-09 1977-06-07 Verfahren zur herstellung neuer derivate von 3- alkyl-1,9-dihydroxy- und -1- hydroxy-9-ketodibenzo(b,d)pyranen

Country Status (28)

Country Link
US (2) US4064009A (de)
JP (1) JPS52151173A (de)
AR (1) AR214636A1 (de)
AT (1) AT356049B (de)
AU (1) AU508677B2 (de)
BE (1) BE855347A (de)
BG (1) BG30773A3 (de)
CA (1) CA1097237A (de)
CH (1) CH640000A5 (de)
CS (1) CS189599B2 (de)
DD (1) DD131020A5 (de)
DE (1) DE2725713A1 (de)
DK (1) DK144971C (de)
ES (1) ES459644A1 (de)
FR (1) FR2354326A1 (de)
GB (1) GB1583062A (de)
GR (1) GR66428B (de)
HU (1) HU174139B (de)
IE (1) IE44992B1 (de)
IL (1) IL52248A (de)
NL (1) NL7706276A (de)
NZ (1) NZ184332A (de)
PH (1) PH12513A (de)
PL (1) PL106942B1 (de)
PT (1) PT66627B (de)
RO (1) RO73175A (de)
SE (1) SE413779B (de)
ZA (1) ZA773467B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948732A (en) * 1989-02-10 1990-08-14 Schering Corporation Microbiological chiral reduction of carbonyl groups
DE4034218A1 (de) * 1990-10-27 1992-04-30 Merck Patent Gmbh Verfahren zur herstellung von carebastin
US6274635B1 (en) 1999-03-22 2001-08-14 Immugen Pharmaceuticals Inc. Alkylated resorcinol derivatives for the treatment of immune diseases
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2003214226A1 (en) * 2002-03-18 2003-10-08 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822188A (en) * 1972-10-19 1974-07-02 Abbott Lab Method of producing 1,4'-dihydroxy-3-n-pentyl-6,6,9-trimethyl-6a,7,10,10a-tetra-hydrodibenzo(b,d)pyran
DE2335136A1 (de) * 1973-07-06 1975-01-16 Schering Ag 7-hydroxy-delta hoch 8-tetrahydrocannabinole

Also Published As

Publication number Publication date
ATA402377A (de) 1979-09-15
CA1097237A (en) 1981-03-10
FR2354326B1 (de) 1980-02-08
DK247077A (da) 1977-12-10
IL52248A (en) 1980-09-16
IE44992L (en) 1977-12-09
ZA773467B (en) 1979-01-31
ES459644A1 (es) 1978-04-01
PL106942B1 (pl) 1980-01-31
RO73175A (ro) 1981-11-24
CH640000A5 (de) 1983-12-15
GR66428B (de) 1981-03-23
SE413779B (sv) 1980-06-23
PL198731A1 (pl) 1978-04-10
SE7706692L (sv) 1977-12-10
PT66627A (en) 1977-07-01
PT66627B (en) 1978-11-09
US4064009A (en) 1977-12-20
JPS52151173A (en) 1977-12-15
DE2725713A1 (de) 1977-12-22
US4104282A (en) 1978-08-01
DK144971C (da) 1982-12-13
NL7706276A (nl) 1977-12-13
AU2593577A (en) 1978-12-14
NZ184332A (en) 1978-09-20
HU174139B (hu) 1979-11-28
CS189599B2 (en) 1979-04-30
IL52248A0 (en) 1977-08-31
AR214636A1 (es) 1979-07-13
FR2354326A1 (fr) 1978-01-06
BG30773A3 (en) 1981-08-14
DK144971B (da) 1982-07-19
IE44992B1 (en) 1982-06-02
GB1583062A (en) 1981-01-21
BE855347A (fr) 1977-12-05
AU508677B2 (en) 1980-03-27
PH12513A (en) 1979-04-20
DD131020A5 (de) 1978-05-24

Similar Documents

Publication Publication Date Title
AT363196B (de) Verfahren zur herstellung von androstan-17-on-derivaten
DD127900A5 (de) Verfahren zur herstellung von mercaptoazetidin-derivaten
ATA936276A (de) Verfahren zur herstellung von neuen, basisch substituierter indolderivate
AT367092B (de) Verfahren zur herstellung von androsten-3,17-dion-derivaten
AT349477B (de) Verfahren zur herstellung von feinteiligem, festem cyanurchlorid
AT356049B (de) Verfahren zur herstellung neuer derivate von 3- alkyl-1,9-dihydroxy- und -1- hydroxy-9-ketodibenzo(b,d)pyranen
AT352120B (de) Verfahren zur herstellung von neuen benzoxocin- derivaten
AT345780B (de) Verfahren zur herstellung von neuem 3,7- dimethyl-3-hydroxyoctannitril
DD131021A5 (de) Verfahren zur herstellung substituierter aminochinazolinderivate
AT356129B (de) Verfahren zur herstellung von substituierten 1-carbamoyl-2-cyanaziridinen
AT356655B (de) Verfahren zur herstellung von neuen benzodia- zepinderivaten
AT361639B (de) Verfahren zur herstellung von 5-androsten-17- -on-derivaten
AT353268B (de) Verfahren zur herstellung von 6a,10a-cis- hexahydrodibenzopyranonen
AT347937B (de) Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten
AT358055B (de) Verfahren zur herstellung von 2-chlor-4,6-bis- -alkylamino-s-triazinen
AT361928B (de) Verfahren zur herstellung von neuen chinolonderivaten
AT353986B (de) Verfahren zur herstellung neuer quartaerer derivate von sandwicin
AT367094B (de) Verfahren zur herstellung von 4-androsten-3,17dion-derivaten
ATA966976A (de) Verfahren zur herstellung von 2-aminoindanderivaten
DD129335A5 (de) Verfahren zur herstellung von androstan-3,17-dion-derivaten
AT364840B (de) Verfahren zur herstellung von 1,3-dimethyl-2-methylimino-4-imidazolidinonderivaten
AT362349B (de) Verfahren zur herstellung von neuen 3-amino-2- -hydroxypropoxyaryl-derivaten
AT353790B (de) Verfahren zur herstellung von indolderivaten
AT382148B (de) Verfahren zur herstellung von chinazolinonderivaten
ATA378379A (de) Verfahren zur herstellung von nitroalkanolderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee